Citations

Clear

1526 citation(s) found for "Sun, Yu".

A33-11 BCL6-Dependent Tissue-Resident Helper T Cells Promote Chronic Lung Sequelae Following Viral Pneumonia
Cheon, I, Son, Y, Im, J -S, Chen, P, Vassallo, R, Sun, J, SON, Youngmin , Vassallo, R.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 18, 2026 | Volume: 212 | Issue: Supplement_1 | Pages: No page available

10.1093/ajrccm/aamag162.4092 Get It

Abstract Respiratory viral infections such as influenza and SARS-CoV-2 can lead to the development of chronic lung disease and impaired pulmonary function long after the recovery from acute illness. However, the mechanisms underlying these post-acute sequelae remain poorly understood. Using human lung samples from patients with post-acute sequelae of COVID-19 with pulmonary fibrosis (PASC-PF) and an aged mouse model of chronic lung disease following acute viral infection, we found that CD4+ T cells were enriched near the dysplastic Krt8Hi epithelial regions of the lung. Similarly, in aged mice, CD4+ T cells localized to Krt8Hi areas, and their spatial distribution correlated positively with the extent of epithelial dysplasia. Further analysis of bronchoalveolar lavage (BAL) fluid from COVID-19 convalescent individuals revealed a distinct population of FoxP3−PD-1HiCD4+ T cells highly expressing ICOS, CD69, and CD103 - markers characteristic of both T follicular helper (TFH) and tissue-resident memory (TRM) cells, which we have defined as tissue-resident helper (TRH) cells previously. Notably, the frequency of these TRH-like cells correlated positively with the extent of reticulate or consolidated regions on chest CT scans, indicative of lung fibrosis. Furthermore, the frequency of these cells was negatively associated with lung functional parameters including forced vital capacity (FVC). These findings suggest that PD-1HiCD4+ TRH-like cells expand in PASC and may contribute to chronic lung sequelae. Given that Bcl6 is required for TRH differentiation, we employed an aged, CD4-specific, inducible Bcl6-deficient (Bcl6iΔCD4) mouse model to evaluate the functional contribution of these cells to post viral lung fibrosis. Bcl6 deficiency led to a marked reduction in total and antigen-specific PD-1HiCD4+ TRH cells, as confirmed by flow cytometry and immunofluorescence. Strikingly, Bcl6 iΔCD4 mice displayed significantly decreased inflammatory and fibrotic lesions in the lung compared to wild-type controls. Moreover, Bcl6 iΔCD4 mice exhibited enhanced lung regeneration, evidenced by increased AT1 and AT2 epithelial cells and improved pulmonary function. Together, these findings identify Bcl6-dependent CD4+ TRH responses as key drivers of post-viral chronic lung sequelae. This study reveals a novel immunopathogenic mechanism linking persistent tissue helper memory T-cell responses to impaired lung repair and fibrosis, providing new insight into the development of post-viral lung disease and potential therapeutic targets for conditions such as respiratory long COVID. This abstract is funded by: American Lung Association, NIH
B101-04 Proteomics of Airway Measures: The SubPopulations and InteRmediate Outcome Measures in COPD Study (SPIROMICS)
Guzman, D E, Ruvuna, L, Sun, Y, Smith, B M, Barjaktarevic, I, Bleecker, E R, Bon, J , Couper, D, Han, M K, Hansel, N N, Hoffman, E A, Krishnan, J A, Ortega, V E, Paine, R, Wells, J M, Woodruff, P G, Bowler, R P, Barr, R G, Wells, J. Michael , Wells, J Michael , Guzman, Diana, Ruvuna, L. , Smith, B M, Han, MeiLan King , Hansel, Nadia N. , Hoffman, Eric A. , Wells, J M, Barr, R. Graham

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 18, 2026 | Volume: 212 | Issue: Supplement_1 | Pages: No page available

10.1093/ajrccm/aamag162.1895 Get It

Abstract Rationale Chronic lower respiratory diseases (CLRD), including chronic obstructive pulmonary disease (COPD), were the third-leading causes of death globally in 2019. Quantitative computed tomography (CT) measures of airway wall and lumen areas are associated with greater respiratory symptoms, reduced FEV1, accelerated lung function decline, and higher risk of incident COPD. Even in individuals without COPD, greater airway wall thickness—corresponding to smaller absolute wall and lumen areas—predicts incident COPD and CLRD-related hospitalizations and mortality. Aims To identify protein signatures and biological pathways underlying airway lumen and wall areas using cross-sectional plasma protein associations with CT measures. Methods SPIROMICS is a multicenter longitudinal case-control study that recruited 2,983 adults with COPD and a 20+ packyear smoking history and controls aged 40-80 years between 2010-2015. Standardized chest CT scans were labeled with airway measures. A total of 1,255 plasma proteins measured by SomaScan were included. Linear regression models adjusted for demographic, clinical, and imaging covariates. Significance was defined by a False Discovery Rate (FDR) p-value (q-value) <0.05 using the Benjamini-Hochberg method. Replication was performed in two external cohorts with inverse variance-weighted meta-analysis. Proteins meeting nominal replication underwent elastic net regression and pathway enrichment (Gene Ontology [GO] and Reactome). Results Among 2,065 participants with CT and proteomic data (mean age 63.2 years, 46.3% women, 61.6% with COPD), proteins meeting replication were significantly associated with lumen area (2 proteins; top hit a disintegrin and metalloproteinase with thrombospondin motifs 5, q = 0.016), wall area (3 proteins; top hit leptin, q = 0.011), and percent wall area (16 proteins; top hit roundabout homolog 2, q = 0.002). Elastic net selected 2 proteins for lumen area, 3 for wall area, and 12 for percent wall area. Pathway enrichment revealed FDR-significant pathways only for percent wall area via GO (50 pathways; top hit axogenesis) and Reactome (1 pathway; diseases of glycosylation). Conclusions This study identified distinct proteins, signatures, and biological pathways associated with CT airway measures of lumen area, wall area, and percent wall area. Proteins linked to airway lumen and wall area are involved in metabolic and vasoactive processes, while those for percent wall area are involved in vascular remodeling, cell adhesion, and extracellular matrix organization—highlighting structural pathophysiologic features of COPD. These findings may inform biomarker discovery and prediction of disease onset and progression. This abstract is funded by: Funding: Daniel E. Guzman, MD, MSE was funded by T32-HL144442. SPIROMICS was supported by contracts from the NIH/NHLBI (HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C, 75N92024D00012), grants from the NIH/NHLBI (U01HL137880, U24HL141762, R01HL182622, R01HL144718, and R01HL093081), and supplemented by contributions made through the Foundation for the NIH and the COPD Foundation from Amgen; AstraZeneca/MedImmune; Bayer; Bellerophon Therapeutics; Boehringer-Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Chiesi Farmaceutici S.p.A.; Forest Research Institute, Inc.; Genentech; GlaxoSmithKline; Grifols Therapeutics, Inc.; Ikaria, Inc.; MGC Diagnostics; Novartis Pharmaceuticals Corporation; Nycomed GmbH; Polarean; ProterixBio; Regeneron Pharmaceuticals, Inc.; Sanofi; Sunovion; Takeda Pharmaceutical Company; Theravance Biopharma; Verona; and Mylan/Viatris.
Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease
Lin, Marlene, Chiotis, Konstantinos , Zhang, J. , Rocha, Salma, Shankar, Ranjani, Amuiri, Alinda, Hammers, Dustin B. , Eloyan, Ani, Kirby, Kala, Koeppe, Robert A, Aisen, Paul, Beckett, Laurel, Kukull, Walter A, Toga, Arthur W, Atri, Alireza, Clark, David, Day, Gregory S, Duara, Ranjan, Graff-Radford, Neill R, Grant, Ian, Honig, Lawrence S, Johnson, Erik C B, Masdeu, Joseph C. , Mendez, Mario F, Onyike, Chiadi U, Riddle, Meghan, Rogalski, Emily, Salloway, Stephen, Sha, Sharon J, Turner, Raymond Scott, Wolk, David A, Womack, Kyle B, Touroutoglou, Alexandra, Vogel, Jacob W, Hoffmann, Thomas J, Carrillo, Maria C, Apostolova, Liana G, Rabinovici, Gil D, Joie, Renaud La , Vogel, Jacob W. , Hammers, Dustin B , Jones, David T , Masdeu, Joseph C , Musiek, Erik , Wingo, Thomas S , Jack, Clifford R , Vemuri, Prashanthi , Dickerson, Bradford Clark , La Joie, Renaud , Chiotis, Konstantinos , Maiti, Piyush , Blazhenets, Ganna , Shankar, Ranjani , Amuiri, Alinda, Eloyan, Ani , Kirby, Kala, Koeppe, Robert A. , Aisen, Paul , Beckett, Laurel , Kukull, Walter A. , Toga, Arthur W. , Atri, Alireza , Clark, David G., Duara, Ranjan , Graff‐Radford, Neill R. , Honig, Lawrence S. , Jones, David T. , Mendez, Mario F. , Onyike, Chiadi U. , Riddle, Meghan , Rogalskı, Emily , Salloway, Stephen , Sha, Sharon J. , Turner, Raymond Scott , Wolk, David A. , Womack, Kyle, Nudelman, Kelly , Touroutoglou, Alexandra , Jack, Clifford R. , Vemuri, Prashanthi , Dufault, Suzanne M. , Hoffmann, Thomas J., Carrillo, María C. , Apostolova, Liana G. , Rabinovici, Gil D.

Mayo Clinic

Brain Communications | May 15, 2026 | Volume: 8 | Issue: 3 | Pages: No page available

10.1093/braincomms/fcag176 | PMID 42255923 Get It

Abstract The growing availability of large-scale biomarker datasets has allowed data-driven methods to characterize Alzheimer’s disease biological heterogeneity. However, most prior studies have focused on cohorts of late-onset amnestic cases, leaving early-onset Alzheimer’s disease underexplored. We aimed to characterize tau-PET-based subtypes through a robust data-driven approach in the Longitudinal Early-Onset Alzheimer’s Disease Study. Baseline [18F]Flortaucipir PET scans from 365 amyloid-PET-positive participants with sporadic early-onset Alzheimer’s disease were quantified in the left and right medial temporal, lateral temporal, occipital, parietal, and frontal cortices. Tau PET values were z-scored against 85 amyloid-PET-negative cognitively normal age-matched participants and fitted into Subtype and Stage Inference (SuStaIn)—an unsupervised clustering algorithm that simultaneously models subtypes and progression from cross-sectional data. The derived subtypes were subsequently characterized by baseline and longitudinal clinical, cognitive, MRI, tau and amyloid PET features. We identified three tau-PET-based subtypes: on average, Subtype 1/Typical (n = 144, 40%) showed a predominant bilateral temporoparietal pattern typical of Alzheimer’s disease. Subtype 2/Left temporal (n = 111, 31%) showed predominant left temporal binding. Subtype 3/Posterior (n = 104, 29%) showed early and permeating occipitoparietal involvement. Subtypes did not differ in demographics or global amyloid burden, but were relatively more enriched for specific clinical presentations: S1/Typical for amnestic presentations, S2/Left Temporal for primary progressive aphasia, and S3/Posterior for posterior cortical atrophy. Baseline tau PET subtypes aligned with cortical atrophy patterns and domain-specific cognitive impairment. When follow-up tau PET scans were fitted to SuStaIn trained on baseline data, 85.6% (n = 172/201) of participants retained the same subtype classification, indicating subtype temporal stability, and progressed within subtypes by 0.56 ± 0.70 SuStaIn stage/year. Longitudinal voxel-wise linear mixed-effects modelling revealed tau accumulation patterns for each subtype in regions relatively spared at baseline: occipital lobe accumulation predominated in S1/Typical, bilateral frontal and right temporal in S2/Left Temporal, and bilateral frontotemporal lobes in S3/Posterior. All subtypes showed longitudinal increases in Clinical Dementia Rating-Sum of Boxes, but with slower worsening in S3/Posterior compared with the other subtypes. Our findings reveal robust subtypes in sporadic early-onset Alzheimer’s disease characterized by distinct spatiotemporal tau patterns that parallel differences in clinical presentations and trajectories of neurodegeneration. These subtypes extend beyond traditional clinical syndromes and support a more nuanced framework for individualized prognosis and care. Incorporating tau PET subtyping into clinical trial design could enable more targeted therapeutic approaches for this younger population.
Predictive Modeling of Early Mortality After Left Ventricular Assist Device Implantation: A Single-Center Exploratory Analysis
Lu, Shi , Liu, Junjiang , Liu, Dingqian , 郝光伟, Tu, Guowei , Guo, Kefang , Dong, L L, Huo, Ran , Lee, Aurora , Wang, Chunsheng, Sun, Xiaoning, Huo, Ran

Mayo Clinic

No container title available | May 12, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-9391241/v1 Get It

Abstract Background: Early postoperative mortality remains a major clinical challenge in left ventricular assist device implantation. Accurate preoperative identification of high-risk patients could optimize candidate selection and improve perioperative management. Methods: From February 2021 to March 2025, 60 patients who underwent LVAD implantation at Zhongshan Hospital, Fudan University were included in the present study. Early mortality was defined as death within 2 months postoperatively, a threshold derived from survival analysis showing a distinct early hazard phase. Preoperative demographic, echocardiographic, hemodynamic, and laboratory variables were evaluated. Predictor selection used least absolute shrinkage and selection operator (LASSO) logistic regression with 10-fold cross-validation, followed by multivariable Firth logistic regression. Internal validation employed bootstrap resampling (1,000 iterations). Results: The mean age was 55 ± 10 years, and 50 (83%) patients had dilated cardiomyopathy. Kaplan–Meier analysis indicated an early hazard phase, with all deaths occurring by ~ 1.7 months after implantation. LASSO selected age, MELD-XI, passive cardiac index (PasCI), and mixed venous oxygen saturation (SvO₂) for multivariable modeling. In the final Firth model, lower SvO₂ (odds ratio [OR] 0.92; 95% CI 0.83–1.00; p = 0.048) and older age (OR 1.13; 95% CI 1.00–1.35; p = 0.059) were associated with higher early mortality. Internal validation yielded an optimism-adjusted AUC of 0.84. Conclusions: In this exploratory study, lower preoperative SvO₂ and older age were the principal predictors of early mortality after LVAD implantation. Our internally validated risk assessment model supports preoperative risk prediction and stratification; however, confirmation in larger, multicenter cohorts is warranted before broader adoption. (246/250)
MYC pathway reprogramming through a TIP60 coactivator switch in neuroendocrine lineage transition in prostate cancer
Sun, Zhen , Zhao, Jimmy, Khan, Zahra, Ismail, Wazim, Han, Teng, Nandakumar, Subhiksha, Young, Serina, Lange, Matthew , Cheng, Pan, Koche, Richard, Schultz, Nikolaus, Sawyers, Charles, Gaspar-Maia, Alexandre , Sawyers, Charles L. , Han, Teng , Nandakumar, Subhiksha , Koche, Richard P , Schultz, Nikolaus D. , Gaspar‐Maia, Alexandre

Mayo Clinic

No container title available | May 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.05.05.723058 | PMID 42146329 Get It

Abstract Prostate adenocarcinomas (PRAD) can acquire resistance to androgen receptor signaling inhibitors through lineage transition to a cell state known as neuroendocrine prostate cancer (NEPC). Using a panel of isogenic PRAD and NEPC mouse tumoroids, we show that NEPC cells acquire new transcription factor (TF) dependencies that function in a previously undefined network. Through selective perturbation of each TF, we identify ASCL1 as a key regulator of NE lineage fate whereas MYCL functions downstream to drive NEPC growth/survival by recruitment of the TIP60/KAT5 acetyltransferase. Interestingly, while dependencies on specific TF family paralogs can vary across NEPC models, all show markedly enhanced dependency on TIP60. Moreover, the H2A.Z-acetyltransferase activity of the TIP60 complex (TIP60-C) is required for NEPC as well as the acetyl-reader BRD8, which is newly incorporated as a TIP60-C subunit with the NEPC transition. Targeted degradation studies in isogenic tumoroids reveal increased dependence on MYCL in NEPC relative to its paralog MYC in PRAD. In addition to a paralog switch (MYC to MYCL), the MYC pathway-addicted NE state is accompanied by a chaperone switch (from TIP60-C to SRCAP) for H2A.Z histone exchange and a coactivator switch (to TIP60) for MYC target gene expression. The NE-specific coupling of MYCL with TIP60 reveals a previously unappreciated opportunity to target MYC-driven NE diseases through pharmacological inhibition of TIP60.
Development of a nomogram for predicting incident heart failure and all-cause mortality in patients with chronic kidney disease: a 3-year follow-up study
Jiang, Yuxin, Song, Xiaotong, Liao, Hongfei, Sun, C J , Zhang, Dingxin , Zhou, Runzhe, Yang, Xiangjie, Wang, Xiaoxia, Li, Dashan, Zhang, Jin, Li, Yan, Wang, Ying, Zhou, Xinyuan , Li, Dashan

Mayo Clinic

Frontiers in Medicine | May 8, 2026 | Volume: 13 | Issue: No issue available | Pages: No page available

10.3389/fmed.2026.1784717 | PMID 42180711 Get It

Background Chronic kidney disease (CKD) confers a substantially elevated risk of cardiovascular (CV) mortality, primarily driven by heart failure (HF) and other CV complications. This study aimed to develop a nomogram for predicting incident HF and all-cause death in patients with CKD, and further identify individuals at high risk of these outcomes. Methods We prospectively recruited 440 patients with CKD stages 3–5 and preserved ejection fraction (LVEF) from a nephropathy center between November 2020 to September 2024. Baseline clinical and demographic characteristics, biochemical and echocardiographic parameters, and data from quality-of-life scales were collected. Key predictors were identified using univariate Cox regression, Lasso, Random Forest, and XGBoost algorithms; these identified predictors were then integrated into a nomogram via multivariate Cox regression. Model performance was assessed using the C-index, ROC analysis, and calibration plots. Results Over 29 months (IQR 24–35), 104(23.6%) patients met the primary composite endpoints, which included 62(14.1%) incident HF and 42(9.5%) all-cause death. After selecting variables through forward stepwise regression, age[HR 1.030, P = 0.016], growth differentiation factor 15(GDF-15) [HR 1.076, P < 0.001], lipoprotein(a)[Lp(a)] [HR = 1.011, P = 0.002], ferritin(FER) [HR = 1.009, P = 0.030], and EuroQol-5D (EQ-5D) score [HR 0.099, P = 0.015] were utilized to construct the nomogram. In the training cohort, the model achieved a C-index of 0.772. For temporal validation, time-dependent area under the ROC curve(AUC) values further confirmed its accuracy: 0.779 (95%CI, 0.696–0.863) at 24 months, 0.816(95%CI, 0.743–0.888) at 27 months, 0.836(95%CI, 0.768–0.903) at 32 months, and 0.850(95%CI, 0.771–0.929) at 36 months. Decision curve analysis (DCA) also demonstrated sustained clinical utility across a broad range of threshold probabilities. Conclusion This study identified specific predictors of HF and all-cause mortality in CKD patients. This model has enhanced predictive ability for early identification of these risks, thereby facilitating timely clinical interventions to improve the prognosis of CKD patients.
Tumor mutational and microbial profiles of early-onset and later-onset colorectal cancers according to detailed tumor location: an international pooled analysis
Ugai, Tomotaka, Ugai, Satoko , Qu, Conghui, Toland, Amanda E., French, Amy J. , Gsur, Andrea , Chan, Andrew T., Guelpen, Bethany van, Lynch, Brigid, Um, Caroline Y., Newton, Christina, Thomas, Claire E., Buchanan, Daniel D., Drew, David, Goode, Ellen L., Aglago, Elom K., Brenner, Hermann, Figueiredo, Jane C., Huyghe, Jeroen R., Nowak, Jonathan A., Doheny, Kimberly F., Hsu, Li, Boardman, Lisa, Gunter, Marc J., Giannakis, Marios, Jenkins, Mark A., Obon-Santacana, Mereia, Hoffmeister, Michael, Song, Mingyang, Murphy, Neil, Campbell, Peter T., He, Qianchuan, Trinh, Quang M., Pai, Rish K. , Steinfelder, Robert S. , Berndt, Sonja I., Gruber, Stephen B., Gallinger, Steven, Zaidi, Syed H., Hudson, Thomas J., Moreno, Victor, Sun, Wei, Huang, Wen-Yi, Lin, Yi, Cao, Yin, Peters, Ulrike, Hullar, Meredith, Phipps, Amanda I., Ugai, Tomotaka , Chen, Yu , Qu, Conghui , Chan, Andrew T , Um, Caroline Y. , Thomas, Claire E. , Buchanan, Daniel D. , Drew, David A. , Aglago, Elom K. , Brenner, Hermann , Figueiredo, Jane C. , Huyghe, Jeroen R. , Nowak, Jonathan A. , Doheny, Kimberly F. , Gunter, Marc J. , Giannakis, Marios , Jenkins, Mark A. , Obón‐Santacana, Mireia , Hoffmeister, Michael , Murphy, Neil , Georgeson, Peter , Campbell, Peter T., Trinh, Quang M. , Berndt, Sonja I. , Brezina, Stefanie , Gruber, Stephen B. , Gallinger, Steven , Zaidi, Syed H., Harrison, Tabitha A. , Hudson, Thomas J , Moreno, Victor , Sun, Wei, Huang, Wen‐Yi , Wang, Xiaoliang , Lin, Yi, Peters, Ulrike , Hullar, Meredith A.J. , Phipps, Amanda I. , Ogino, Shuji

Mayo Clinic

International Journal of Surgery | May 6, 2026 | Volume: 112 | Issue: 5 | Pages: 11070-11085

10.1097/js9.0000000000003877 Get It

Background: Considering the pathophysiological importance of the intestine-passing microbiota, we hypothesized that the mutational and microbial profiles of colorectal cancer might gradually change along detailed anatomical locations and that these trends might differ by the age of diagnosis and the microsatellite instability (MSI) status. Methods: We assessed somatic mutations and selected bacterial species in colorectal carcinomas along the cecum, ascending colon, transverse colon, descending colon, sigmoid colon, and rectum, utilizing targeted sequencing data ( N = 5685) from the Genetics and Epidemiology of Colorectal Cancer Consortium and tissue microbial data ( N = 1389) from the Health Professionals Follow-up Study and Nurses’ Health Study. Results: There were decreasing trends from the cecum to rectum in the prevalence of gene mutations in the IGF/PI3K, receptor tyrosine kinase (RTK)/RAS, TGFB, and WNT signaling pathways (all P trend < 0.0001), as well as high levels of Bacteroides fragilis ( P trend < 0.0001) and high levels of Fusobacterium nucleatum ( P trend = 0.0029) (but not enterotoxigenic Bacteroides fragilis or pks+ Escherichia coli ). Conversely, TP53 pathway mutations showed an increasing cecum-to-rectum trend ( P trend < 0.0001). Similar to later-onset cases diagnosed at ages 50 years and older, in early-onset cases diagnosed under the age of 50 years, we found generally decreasing cecum-to-rectum trends of IGF/PI3K, RTK/RAS, TGFB, and WNT pathway mutations and an increasing cecum-to-rectum trend in TP53 pathway mutations. By contrast, the cecum-to-rectum prevalence-changing trends in IGF/PI3K, RTK/RAS, TGFB, and TP53 pathway mutations were present in non–MSI-high tumors but not in MSI-high tumors (all P interaction < 0.0052). Conclusion: Non–MSI-high colorectal cancers exhibited decreasing cecum-to-rectum trends of IGF/PI3K, RTK/RAS, and TGFB pathway mutations (and an increasing trend of TP53 pathway mutations), in contrast to MSI-high tumors that demonstrated no such trends. Our study highlights the importance of detailed colorectal subsite information combined with tumor molecular and microbial characteristics in colorectal cancer research.
ceQTL: a co-expression QTL model to detect a variant that affects transcription factor binding and its target regulation
Wang, Panwen , Chen, Yanxi, Liu, Yong, Yang, Ping , Wang, Junwen , Sun, Zhifu, Liu, Li , Yang, Ping , Wang, Junwen , Chen, Yanxi, Liu, Yong, Liu, Li

Mayo Clinic

Briefings in Bioinformatics | May 5, 2026 | Volume: 27 | Issue: 3 | Pages: No page available

10.1093/bib/bbag258 | PMID 42202282 Get It

Abstract Expression quantitative trait locus (eQTL) mapping is used to identify the functional link between a genomic variant and a gene’s expression. A significant eQTL association does not mean a causal relationship or mechanism, and further investigation is needed to understand how a single-nucleotide polymorphism (SNP) impacts gene expression. One of the most plausible explanations for eQTL is that a genomic variant affects transcription factor (TF) binding and thus impacts its regulation on target genes (TGs). However, the current eQTL model does not provide information on the TF and how its regulation is mediated by the SNP’s genotypes. Here, we propose a new method called differential co-expression QTL (ceQTL) among different alleles using Chow statistics to specifically detect eQTLs that are bound by a particular TF. We start with building a trio of TF, its TG, and related SNP, and then test the significant coefficient difference among different genotypes of the SNP. We applied this ceQTL model to simulated data and the lung tissue datasets from the genotype-tissue expression project. The simulated data results showed that the model was robust to detect true ceQTLs at variable sample sizes and different minor allele frequencies as measured by area under the curve. Our tool also performed a TF binding affinity analysis to add another layer of evidence for functional interpretation. In summary, ceQTL analysis provides a more interpretable and biological insight into the mechanism of eQTL and transcriptomic regulation, which would help us better understand how genomic variants affect phenotypes and diseases.
Association between bisphenols A and the risk of endometriosis: results from an updated meta-analysis
Chen, Yue, Wu, Junle, Wang, Yuxin , Yang, Qingxin, Zhu, Yan, Zhou, Qin, Li, Panpan, Wang, Fuke, Sun, Chenyu

Mayo Clinic

Frontiers in Public Health | May 4, 2026 | Volume: 14 | Issue: No issue available | Pages: No page available

10.3389/fpubh.2026.1817156 | PMID 42158187 Get It

Background Recent studies have disputed the association between bisphenol A (BPA) and endometriosis. This updated meta-analysis was conducted to investigate the impact of BPA exposure on endometriosis. Methods This study evaluated BPA exposure and endometriosis risk, analyzing studies from Web of Science, PubMed, Embase, Cochrane Library, and Chinese databases (CNKI, CBM, Wanfang, VIP) through August 2025. Methodological quality was assessed via the Newcastle-Ottawa Scale (NOS) and the Agency for Healthcare Research and Quality Tool (AHRQ). Heterogeneity was quantified using I 2 statistics. Pooled odds ratios (ORs) and 95% CIs were calculated using fixed- or random-effects models according to heterogeneity. Subgroup analysis, sensitivity analysis, and publication bias assessment were supplemented to validate the overall finding. Results Seven studies comprising 2,488 participants were included in quantitative synthesis. The meta-analyses demonstrated that BPA exposure was associated with a statistically significant increase in endometriosis risk (OR = 1.36, 95% CI = 1.13–1.63, p = 0.008). Additionally, subgroup analysis indicated that BPA exposure may further elevate endometriosis risk in cases with different regions, populations, and measurement methods. Sensitivity analysis confirmed that the results of these meta-analyses were relatively robust. No publication bias was detected. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420251019552 , identifier PROSPERO (CRD420251019552).
Criterion and convergent validity of plasma biomarkers in early‐onset Alzheimer's disease: Initial findings from LEADS
Hammers, Dustin B., Polsinelli, Angelina, Eloyan, Ani, Taurone, Alexander, Thangarajah, Maryanne, Foroud, Tatiana, Gao, Sujuan, Beckett, Laurel, Joie, Renaud La, Touroutoglou, Alexandra, Vemuri, Prashanthi, Zetterberg, Henrik, Blennow, Kaj, Nemes, Sára , Костадинова, Ралица, Aisen, Paul, Nudelman, Kelly N., Kirby, Kala, Atri, Alireza, Clark, David, Day, Gregory S., Duara, Ranjan, Graff‐Radford, Neill R., Grant, Ian, Honig, Lawrence S., Johnson, Erik C. B., Jones, David T., Masdeu, Joseph C., Mendez, Mario F., Parand, Leila, Womack, Kyle, Musiek, Erik, Onyike, Chiadi U., Riddle, Meghan, Rogalskı, Emily , Salloway, Stephen, Sha, Sharon J., Turner, Raymond Scott, Wingo, Thomas S., Wolk, David A., Carrillo, Maria C., Rabinovici, Gil D., Dickerson, Bradford C., Dage, Jeffrey L., Apostolova, Liana G., Carrillo, María C. , Rabinovici, Gil D. , Joie, Renaud La , Polsinelli, Angelina J. , La Joie, Renaud , Rabinovici, Gil D , Hammers, Dustin B , Eloyan, Ani , Taurone, Alexander, Thangarajah, Maryanne, Foroud, Tatiana , Gao, Sujuan , Beckett, Laurel , Touroutoglou, Alexandra , Vemuri, Prashanthi , Zetterberg, Henrik , Blennow, Kaj , Kostadinova, Ralitsa, Aisen, Paul , Nudelman, Kelly , Kirby, Kala, Atri, Alireza , Clark, David, Day, Gregory S. , Duara, Ranjan , Graff‐Radford, Neill R. , Honig, Lawrence S. , Johnson, Erik C. B. , Jones, David T. , Masdeu, Joseph C , Mendez, Mario F. , Womack, Kyle , Musiek, Erik , Onyike, Chiadi U. , Riddle, Meghan , Salloway, Stephen , Sha, Sharon J. , Turner, Raymond Scott , Wingo, Thomas S , Wolk, David A. , Dickerson, Bradford Clark , Dage, Jeffrey L. , Apostolova, Liana G.

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | May 4, 2026 | Volume: 18 | Issue: 2 | Pages: No page available

10.1002/dad2.70342 | PMID 42088846 Get It

Abstract INTRODUCTION : Despite expanding use of plasma biomarkers for Alzheimer's disease (AD), minimal examination has been undertaken in early‐onset AD (EOAD). Prior analyses assessed criterion and convergent validity of common plasma biomarkers in a well‐characterized sample with sporadic EOAD. METHODS : Plasma amyloid beta (Aβ) 42/40, tau phosphorylated at threonine 231 (p‐tau231), glial fibrillary acidic protein (GFAP), and neurofilament light change (NfL) levels were obtained for 189 EOAD, 52 early‐onset non‐AD (EOnonAD), and 83 cognitively normal (CN) participants. Diagnostic group differences, convergence with imaging biomarkers, and the capacity to predict specific cognitive domains were investigated. RESULTS : After controlling for cognitive status, EOAD participants exhibited more pathologic levels of Aβ42/40, p‐tau231, and GFAP relative to EOnonAD participants. However, NfL displayed the greatest sensitivity to non‐amnestic cognitive impairment across the sample. DISCUSSION : These results establish criterion and convergent validity of plasma biomarkers in sporadic EOAD and highlight complementary roles that AD‐specific and non‐specific plasma markers may play across the course of AD care.